Homo sapiens Protein: EGR2
Summary
InnateDB Protein IDBP-377438.5
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol EGR2
Protein Name early growth response 2
Synonyms AT591; CMT1D; CMT4E; KROX20;
Species Homo sapiens
Ensembl Protein ENSP00000387634
InnateDB Gene IDBG-75626 (EGR2)
Protein Structure
UniProt Annotation
Function Sequence-specific DNA-binding transcription factor. Binds to two specific DNA sites located in the promoter region of HOXA4. {ECO:0000269PubMed:21836637}.E3 SUMO-protein ligase helping SUMO1 conjugation to its coregulators NAB1 and NAB2, whose sumoylation down-regulates EGR2 own transcriptional activity. {ECO:0000269PubMed:21836637}.
Subcellular Localization Nucleus.
Disease Associations Neuropathy, congenital hypomyelinating or amyelinating (CHN) [MIM:605253]: A severe degenerating neuropathy that results from a congenital impairment in myelin formation. It is clinically characterized by early onset of hypotonia, areflexia, distal muscle weakness, and very slow nerve conduction velocities (as low as 3m/s). Some patients manifest nearly complete absence of spontaneous limb movements, respiratory distress at birth, and complete absence of myelin shown by electron microscopy of peripheral nerves. Inheritance can be autosomal dominant or recessive. {ECO:0000269PubMed:22522483, ECO:0000269PubMed:9537424}. Note=The disease is caused by mutations affecting the gene represented in this entry. Patients affected by the amyelinating form carry a causative, homozygous deletion encompassing a myelin-specific enhancer of EGR2 (PubMed:22522483). {ECO:0000269PubMed:22522483}.Charcot-Marie-Tooth disease 1D (CMT1D) [MIM:607678]: A dominant demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot- Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. {ECO:0000269PubMed:10502832, ECO:0000269PubMed:10762521, ECO:0000269PubMed:11239949, ECO:0000269PubMed:12736090, ECO:0000269PubMed:15241803, ECO:0000269PubMed:15947997, ECO:0000269PubMed:9537424, ECO:0000269Ref.15}. Note=The disease is caused by mutations affecting the gene represented in this entry.Dejerine-Sottas syndrome (DSS) [MIM:145900]: A severe degenerating neuropathy of the demyelinating Charcot-Marie-Tooth disease category, with onset by age 2 years. Characterized by motor and sensory neuropathy with very slow nerve conduction velocities, increased cerebrospinal fluid protein concentrations, hypertrophic nerve changes, delayed age of walking as well as areflexia. There are both autosomal dominant and autosomal recessive forms of Dejerine-Sottas syndrome. {ECO:0000269PubMed:10371530}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 25 experimentally validated interaction(s) in this database.
They are also associated with 9 interaction(s) predicted by orthology.
Experimentally validated
Total 25 [view]
Protein-Protein 18 [view]
Protein-DNA 7 [view]
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 9 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0001102 RNA polymerase II activating transcription factor binding
GO:0003682 chromatin binding
GO:0003700 sequence-specific DNA binding transcription factor activity
GO:0005515 protein binding
GO:0016874 ligase activity
GO:0031625 ubiquitin protein ligase binding
GO:0044212 transcription regulatory region DNA binding
GO:0046872 metal ion binding
Biological Process
GO:0006366 transcription from RNA polymerase II promoter
GO:0006611 protein export from nucleus
GO:0007420 brain development
GO:0007422 peripheral nervous system development
GO:0008219 cell death
GO:0016925 protein sumoylation
GO:0035914 skeletal muscle cell differentiation
GO:0042552 myelination
GO:0043066 negative regulation of apoptotic process
GO:0045444 fat cell differentiation
GO:0045893 positive regulation of transcription, DNA-templated
GO:0048168 regulation of neuronal synaptic plasticity
GO:0071320 cellular response to cAMP
GO:0071371 cellular response to gonadotropin stimulus
Cellular Component
GO:0005634 nucleus
GO:0005737 cytoplasm
Protein Structure and Domains
PDB ID
InterPro IPR007087 Zinc finger, C2H2
IPR015880 Zinc finger, C2H2-like
IPR021849 Protein of unknown function DUF3446
PFAM PF00096
PF11928
PRINTS
PIRSF
SMART SM00355
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt P11161
PhosphoSite PhosphoSite-P11161
TrEMBL
UniProt Splice Variant
Entrez Gene 1959
UniGene Hs.736842
RefSeq NP_001129651
HUGO HGNC:3239
OMIM 129010
CCDS CCDS44409
HPRD 00551
IMGT
EMBL AF139463 AK091399 AK312813 AL133417 BC035625 CH471083 CR749641 J04076 X53700
GenPept AAA52372 AAD24588 AAH35625 BAG35671 BAG52349 CAH18435 CAH73827 EAW54238 EAW54239